GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Ending Cash Position

Incanthera (AQSE:INC) Ending Cash Position : £-0.00 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Ending Cash Position?

Incanthera's Ending Cash Position for the quarter that ended in Sep. 2023 was £-0.00 Mil.

Incanthera's quarterly Ending Cash Position declined from Sep. 2022 (£0.03 Mil) to Mar. 2023 (£0.00 Mil) and declined from Mar. 2023 (£0.00 Mil) to Sep. 2023 (£-0.00 Mil).

Incanthera's annual Ending Cash Position declined from Mar. 2021 (£0.96 Mil) to Mar. 2022 (£0.30 Mil) and declined from Mar. 2022 (£0.30 Mil) to Mar. 2023 (£0.00 Mil).


Incanthera Ending Cash Position Historical Data

The historical data trend for Incanthera's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Ending Cash Position Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Ending Cash Position
0.39 0.96 0.30 -

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Ending Cash Position Get a 7-Day Free Trial 0.63 0.30 0.03 - -

Incanthera Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Incanthera's Ending Cash Position for the fiscal year that ended in Mar. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.296+-0.293
=0.00

Incanthera's Ending Cash Position for the quarter that ended in Sep. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.003+-0.007
=-0.00


Incanthera Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Incanthera's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Incanthera (AQSE:INC) Business Description

Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines